This library has spent a lot of words on what individual documents and studies establish. It is worth closing the loop and stating the boundary directly, because the most common failure in this market is not a false claim, it is a true claim asked to carry weight it was never built for.
Four questions that get treated as one
Answering one says nothing about the others
- Is it the right molecule?
- Mass spectrometry: expected against found mass, with a stated tolerance. Sequence-level confirmation needs tandem MS.
- How much of the sample is it?
- Chromatographic purity, a relative peak area under one stated method, blind to whatever the detector cannot see.
- How much of the vial is compound?
- Peptide content, from amino acid analysis. The number that converts label mass into molar amount, and the one most often absent.
- Is it biologically clean?
- Sterility and endotoxin, separate assays, normally not performed on research-grade material.
- What does it do in a person?
- Not an analytical question at all. Answered only by clinical study, and for most of this catalogue there is none.
Notice that these do not form a scale. They are not degrees of the same property, where satisfying the harder ones implies the easier. They are answers to unrelated questions, each requiring its own measurement.
A vial can be unambiguously the right molecule, 99% pure by chromatography, and carry a substantial endotoxin load, because the instrument that established the purity figure was never looking. That specific gap is the subject of sterile, pyrogen-free, research grade.
Equally, a preparation can pass every analytical test and contain 20-30% less peptide than the label mass implies, because counter-ion and residual water were weighed along with it. That is salt form and peptide content, and it is why the missing number matters more than the impressive one.
What analysis can genuinely establish
It is worth being clear that these documents are not theatre. Done properly they are strong evidence about material.
Mass spectrometry is a decisive identity test. A missing residue shifts the mass by a discrete, predictable amount, and no amount of co-elution hides it, the argument in the impurity that behaves like the compound.
Chromatographic purity, reported with its method, is a reproducible measure of how thoroughly synthesis-related impurities were removed1. Those impurities are exactly the species that would confound an experiment, so removing them matters and measuring the removal matters.
Between them, the two tests cover each other's blind spots. That is a real accomplishment and the reason both belong on a certificate.
The snapshot problem
What analysis cannot do is describe the material in your hand.
Everything after the analysis is outside the document's scope
Batch synthesised and purified
Deletion sequences removed as far as the process allows
Analysed
Identity, purity, sometimes content, measured on a sample, on a date
Stored and shipped
Time, temperature and humidity now act on the material
Reconstituted and handled
Water restarts degradation; handling can aggregate. None of this is on the certificate
A certificate reports measurements made on a sample, on a date. Everything after that, storage time, temperature excursions, the humidity in the room when the vial was opened, the solvent chosen, the number of freeze, thaw cycles, acts on the material and appears nowhere in the document.
This is not a criticism of certificates; it is what a dated report is. But it does mean that documentation and handling are complements rather than substitutes. The degradation routes that operate after testing are well characterised2, and they are the subject of most of the practical pieces in this library: why peptides ship as powder, aliquot first, choosing the solvent.
Where the literature stops
The other body of evidence is published research, and it has its own boundary.
For most compounds in this catalogue the record consists of in-vitro work and animal studies, sometimes with a small early human study. Each of those is informative about the system it was run in. None establishes what happens in a person, and the gap is wider than publication volume suggests, the argument in what an animal result is actually worth.
Two specific failure modes recur. Concentrations used in cell work may be unreachable in an organism, discussed in the concentration in the dish. And doses quoted from animal work are frequently converted to human figures in the wrong direction, as set out in why a mouse dose does not become a human dose.
The claim nobody's paperwork can make
Put all of it together, flawless identity, high purity, stated peptide content, careful storage, a substantial published literature, and one question remains untouched.
Whether the material is suitable for use in a human being is not an analytical question. It is answered by clinical study: dose-finding, controlled trials, safety monitoring, regulatory review. For the compounds described here, that work has largely not been done, and no certificate can substitute for it. A document proves that a molecule is what it says it is. It cannot prove that anyone should take it.
That is the honest position, and it is the same one stated on every product page on this site. The paperwork tells you what you have. It does not tell you what to do with it, and a supplier who implies otherwise is selling the document rather than the material.
